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Abstract
Background: Visits to the primary diabetes care provider play a central role in diabetes care. Therefore, patients
should attend their primary diabetes care providers whenever a visit is necessary. Parameters that might affect
whether this condition is fulfilled include accessibility (in terms of travel distance and travel time to the practice), as
well as aspects of service quality (for example in-practice waiting time and quality of the provider’s communication
with the patient). The relationships of these variables with the frequency of visits to the primary diabetes care
provider are investigated.
Methods: The investigation is performed with questionnaire data of 1086 type 2 diabetes patients from study
regions in England (213), Finland (135), Germany (218), Greece (153), the Netherlands (296) and Spain (71). Data
were collected between October 2011 and March 2012. Data were analysed using log-linear Poisson regression
models with self-reported numbers of visits in a year to the primary diabetes care provider as the criterion variable.
Predictor variables of the core model were: country; gender; age; education; stage of diabetes; heart problems;
previous stroke; problems with lower extremities; problems with sight; kidney problems; travel distance and travel
time; in-practice waiting time; and quality of communication. To test region-specific characteristics, the interaction
between the latter four predictor variables and study region was also investigated.
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Results: When study regions are merged, travel distance and in-practice waiting time have a negative effect, travel
time no effect and quality of communication a positive effect on visit frequency (with the latter effect being by far
largest). When region specific effects are considered, there are strong interaction effects shown for travel distance,
in-practice waiting time and quality of communication. For travel distance, as well as for in-practice waiting time,
there are region-specific effects in opposite directions. For quality of communication, there are only differences in
the strength with which visit frequency increases with this variable.
Conclusions: The impact of quality of communication on visit frequency is the largest and is stable across all study
regions. Hence, increasing quality of communication seems to be the best approach for increasing visit frequency.
Keywords: Travel distance, Travel time, In-practice waiting time, Provider-patient communication, Health care
provider, Visit, Accessibility to care, Type 2 diabetes
Background
Global diabetes prevalence in 2019 is estimated to be
9.3% (463 million people), rising to 10.2% (578 million)
by 2030 and 10.9% (700 million) by 2045 [1] and, hence,
diabetes care constitutes an important part of health
care provision. Although diabetes can lead to a wide
range of medical complications involving a range of dif-
ferent care professionals there is usually only one lead
clinician that coordinates and provides the majority of
this care. In the following text, this person is referred to
as the primary diabetes care provider. In most cases, this
primary diabetes care provider is a general practitioner
or, in some countries, a specialist diabetes nurse. The
primary diabetes care provider diagnoses the patient’s
medical condition; discusses the treatment with the pa-
tient; provides drugs and any necessary medical equip-
ment required for the treatment; counsels the patient;
and supervises the patient’s adherence to the treatment
regime. However, this can only be done if patients visit
their primary care provider sufficiently frequently and
diabetes care needs to be designed and organised to fa-
cilitate this. This, in turn, requires knowledge about the
determinants of patient visits to the primary diabetes
care provider.
Certainly, the most important determinant of visits to
the primary diabetes care provider is cost: whether the
patients must pay for the visit out of their own pocket;
whether any costs are reimbursed through a health in-
surance scheme; or whether the system is financed
through general taxation. There might, however, be
other factors that affect the frequency of visits to the
provider, which become more prominent once any cost
issues are removed. These include the accessibility of the
provider to the patient and the service quality of the
provider. Important aspects of accessibility are travel dis-
tance and travel time from patient residence to provider
location. Important aspects of the provider’s service
quality, i.e. the extent to which the provider tries to re-
spect the patients’ needs in all regards related to their
interaction, are waiting time in the providers’ practice to
see the clinician (i.e. the in-practice waiting time) and
the quality of the provider’s communication with the pa-
tient. Long travel distances, long travel times, long in-
practice waiting times (or combinations of these of these
circumstances) might negatively affect the number of
visits, whereas quality of communication might have a
positive effect.
Several studies provide relevant evidence for the hy-
potheses formulated above. There are statistically signifi-
cant negative associations between travel distance and
visits to primary care providers [2], attendance at hos-
pital emergency departments [3], frequency of visits to a
dentist following traumatic dental injury [4], the decision
to attend screening for gestational diabetes mellitus [5],
the use of insulin [12] and glycaemic control [13 and 14]
However, there was no statistically significant relation-
ship with compliance for mammography [6] and health-
related quality of life [7]. Other studies have produced
statistically significant negative associations of travel
time with the tendency to visit an endocrinologist [8],
the likelihood of visiting a physician [9], the likelihood of
attending a hospital [9], the likelihood of in-facility deliv-
ery [10], the frequency of pre-natal care visits [10, 11],
and health-related quality of life [7]. However, there was
no statistically significant association with the likelihood
of visiting a general practitioner [15, 16], the likelihood
of visiting a gynaecologist [16], compliance to mammog-
raphy [6] and the delay in seeking care in case of a mal-
aria infection [17]. Further studies have produced
statistically significant associations of in-practice waiting
time with frequency of physician visits [18] and health-
related quality of life [7]. Moreover, some studies [19–
21] show that quality of communication with the
provider is positively associated with self-care.
At present, there is no study regarding the relationship
of travel distance, travel time, in-practice waiting time
and quality of provider-patient communication with the
frequency of visiting the primary diabetes care provider.
This study redresses that gap in the research literature
with regard to care for diabetes type 2.
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Methods
Study regions, study participants and study conduction
The investigation is based on the same data set that was
used by Konerding et al. [7] to investigate the impact of
travel distance, travel time and in-practice waiting time
on health-related quality of life. These data were origin-
ally collected in the European FP-7 project ‘MANAGED
OUTCOMES’ [22, 23], which was concerned with ana-
lysing health care provider networks in England, Finland,
Germany, Greece, the Netherlands and Spain. In all of
these countries, the majority of medical services are
either reimbursed by health insurances or financed
through taxation. However, there are differences be-
tween each country as to how the access to health care
is regulated. In terms of the classification system of
Reibling [24], England, the Netherlands and Spain are
strong gatekeeping and low supply states, i.e. these states
strongly regulate access to health care providers by hav-
ing clinical expert ‘gatekeepers’ (general practitioners)
decide which service should be provided to the patient.
In turn, this means that these states – in theory at least
- can have a lower supply of health care. Germany and
Greece, by contrast, are weakly regulated and high sup-
ply states in the terminology of Reibling, i.e. these states
have minimal gatekeeper control, which means that they
have to provide a high supply of health care. Finally, in
Reibling’s terminology, Finland is a ‘mixed regulation
state’, i.e. this state regulates access to health service par-
tially by gatekeeping and partially by cost sharing and has
a moderate supply of health care [23].
In the MANAGED OUTCOMES project, health pro-
vider networks for different health conditions were inves-
tigated, including networks for providing type 2 diabetes
care. For each country, one local network was selected
and data were collected from the diabetes service locations
in these networks. In England these locations were seven
general practitioner practices associated with the Tower
Hamlets Primary Care Trust in the east London Borough
of Tower Hamlets. In Finland, these were the health cen-
tres of eight municipalities within Keski-Suomi (Central
Finland). In Germany, these were one general practitioner
and one diabetologist in the city of Bamberg, and two gen-
eral practitioners and one diabetologist in the surrounding
rural district of Bamberg. In Greece, these were five differ-
ent institutions providing outpatient care for diabetes in
the regional unit of Heraklion on the island of Crete. In
the Netherlands, these were five general practitioner
health centres in the region Nieuwe Waterweg Noord en
Delft Westland Oostland. In Spain, this was one primary
health area in the region of Valencia [7]. The main criter-
ion for selecting the locations and health care providers
was their willingness to cooperate in the study.
Part of the investigation comprised surveys of type 2
diabetes patients, which were undertaken with the
assistance of the investigated primary diabetes care pro-
viders. These providers selected the patients to be
approached for participation according to criteria de-
fined by the researchers. Inclusion criteria for partici-
pants were (1) that they were being treated for type 2
diabetes by the health providers investigated in the pro-
ject and (2) that they were at least 18 years old. Depend-
ing on the most feasible method for each provider,
patients were contacted either by post or directly when
they visited their primary diabetes care provider. Patients
who participated in the survey completed their question-
naires on their own without any intervention by
personnel from the service provider or the research
team. Depending on the most feasible method for the
particular provider, participants then returned their
completed questionnaires either by post directly to the
local project study centres, or to the care provider who
then passed them on to the study centres. With the ex-
ception of Greece, all surveys were approved by national
ethics committees. In Greece, the approval was granted
by the relevant committee of the hospital. Data were col-
lected between October 2011 and March 2012 [7].
Questionnaire variables
The patient questionnaire applied in the survey con-
tained questions addressing different topics. Two items
addressed the mastery of the questionnaire language.
Demographic data items included: sex, age and educa-
tional level of the patient (those leaving school directly
after the minimum school leaving age of the country
were classified as ‘low level’; those who had stayed in
education beyond that were classified as ‘high level’).
Health data items included the stage of diabetes, which
was characterised by the three levels of treatment: (1)
diet only (2) oral anti-diabetic agents but no insulin, and
(3) insulin. The patients were also asked about any of
five secondary complications they might have had arising
from the diabetes: heart problems; previous stroke; prob-
lems with lower extremities; problems with sight; and
kidney problems (either having had a kidney transplant
or being dependent on dialysis). Other data referred to
the diabetes service they attended: travel time; travel dis-
tance; in-practice waiting time; quality of communica-
tion; and the number of visits to the primary diabetes
care provider within the last year (see Table 1).
The questions addressing mastery of the questionnaire
language were included in order to determine the sam-
ple of participants included in the analyses, while all of
the other variables were considered in the analyses
themselves. In the following sections, these will be re-
ferred to as the ‘investigated variables’. According to
their status in the statistical analyses, the investigated
variables were subdivided into three categories. The
number of provider visits, i.e. visit frequency, was
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classified as the criterion variable; travel time, travel dis-
tance, in-practice waiting time and quality of communi-
cation were classified as ‘focal predictor’ variables, and
all remaining investigated variables were applied as con-
trol variables.
Inclusion criteria
Patients were only included in the analysis if they had
indicated that they mastered the questionnaire lan-
guage well, and if they had given information about
travel time; travel distance; in-practice waiting time,
quality of communication; and the number of pro-
vider visits they had in the last year. Patients were ex-
cluded from analyses if data for more than two
control variables were missing. The strict criteria with
regard to missing data were chosen, because the
number of missing data was assumed to reflect the
thoroughness with which the respondent has an-
swered the questionnaire. Accordingly, data of pa-
tients with more than two missing data were assumed
to be less reliable and less valid than data of the
other patients and it therefore seemed wise to exclude
them from the analyses.
Patients were included independently of the number
of visits to their primary diabetes care provider in the
year preceding the survey, i.e. patients who had not vis-
ited at all during this time were also included. This was
necessary because the relationship of the focal predictor
variables with the number of visits was investigated and
because ‘zero visits’ constituted a possible outcome. It
could be argued that the answers given by patients with
zero visits in the last year are less valid than the answers
of regular visitors. However, even if they are less valid in
the sense that they do not adequately describe the reality
they can validly reflect what the patients think about the
reality and it is this thinking which determines the be-
haviour [25].
Statistical analyses
For the inclusion criteria, descriptive statistics were
computed based on the total number of questionnaires
distributed and, for the investigated variables, based on
the questionnaires which met the inclusion criteria. Per-
centages were computed for dichotomous variables, and
means, standard deviations, minima and maxima for
continuous variables. This was undertaken for both the
total sample and separately for the six region-specific
samples. Regional differences regarding dichotomous
variables were statistically tested using chi-square tests,
and regional differences regarding continuous variables
using Kruskal-Wallis tests.
The relationship of travel distance, travel time, in-
practice waiting time and quality of communication with
visits to the primary diabetes care provider was
investigated using log-linear Poisson regression models
[26] with frequency of visits as the criterion. Poisson re-
gression models are specially designed for predicting
count variables as for example the frequency of visits.
The de-logarithmised coefficients estimated by these
models reflect the proportion with which the predicted
variable increases or, respectively, decreases when the
corresponding predictor variable increases by one unit.
All focal predictor variables and all control variables
were applied as predictor variables. All focal predictors
were entered together into the same model as they were
considered to reflect different aspects. This also applies
to travel distance and travel time because travel time is
not solely determined by travel distance, but also by fac-
tors such as the method of transport available to the pa-
tient and road congestion. Hence, both variables might
have an independent effect on the visits to the diabetes
care provider. Dummy-coded study regions were in-
cluded to control for region-specific tendencies regard-
ing provider visits. The status of diabetes and the five
secondary complications of diabetes were included to
control for the effect of health status because health sta-
tus usually affects the number of health care provider
visits [2–4, 8, 9, 15]. The three socio-demographic vari-
ables (age, gender and education) were included because
these variables are known to be related to health status
[27–30] and thus might help to control for those aspects
of health status that are not reflected by diabetes status
and secondary complications. Taken together, the demo-
graphic variables and the variables directly addressing
health status can be regarded as variables covering the
need for visits to the primary diabetes care provider.
The coefficients for all predictor variables were esti-
mated and tested for deviation from zero. Fit of the
models was investigated by comparing the complete
model via a likelihood ratio test with only the criterion
mean as predictor and by using the index proposed by
Cameron and Windmeijer [31] (CW-index).1 The CW-
index serves a similar purpose as the multiple R square
in multivariate linear regression. This index is 0 when
the model predicts the criterion as poorly as the criter-
ion mean, and it is 1 when the model predicts the criter-
ion optimally. The extent to which a specific predictor
variable contributes to predicting visit frequency was
assessed by subtracting the CW-index for a model with-
out this variable from the CW-index for the complete
model. To obtain a statistic that can be interpreted
analogously to the percentage of variance exclusively ex-
plained by a specific predictor variable in a multivariate
regression model, the resulting difference was multiplied
1Following a convention reported by Greene [26] ln (0) was set equal
to zero when CW-indices were computed.
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Table 1 Questions in the questionnaire applied for the investigation
aFor all other countries than England the respective national language was inserted
bFor all other countries than England kilometres were asked. For the statistical analyses, the English miles were transformed into kilometres
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by 100. In contrast to the coefficient belonging to a pre-
dictor variable, the statistic just described is independent
of the unit with which the predictor variable is mea-
sured. Therefore, by means of this statistic, the contribu-
tions of different predictor variables can be compared.
The correlations between the focal predictors were
computed and, to investigate the influence of these cor-
relations on the results, four additional models were
computed in each of which a different focal predictor
was omitted.
To investigate the stability of the results across the six
study regions, the interactions between the focal pre-
dictor variables and the study regions were analysed.
The statistical significance for the interactions with a
specific focal predictor was tested via a likelihood ratio
test by comparing a model containing all predictor vari-
ables and all investigated interactions with a model from
which the interaction terms for the respective focal pre-
dictor variable had been removed. In addition, the con-
tribution of the interaction for explaining the visit
frequency was investigated using CW-indices in an
analogous manner as described above for the main ef-
fects. To investigate the extent to which possible interac-
tions can be attributed to the countries’ health care
systems, analogue computations were performed after
grouping the study regions according to the Reibling cat-
egories assigned to the corresponding country [23, 24]
(see above).
To check the generalisability of the results, all analyses
were performed in two variants: 1) for all included par-
ticipants (i.e. persons who had up to two missing data
items for the control variables), and 2) for participants
with complete data for all investigated variables. For the
analysis referring to participants with missing values,
the missing values were imputed by the study region-
specific means. As data possessing less than interval
scale level were dummy coded, the study region-
specific relative frequencies of persons belonging to
the respective category were taken for imputing miss-
ing values of these data.
Results
Altogether 6245 questionnaires were distributed of
which 1638 (26.2%) were returned and 1086 (17.4%) met
the inclusion criteria (see Table 2). The proportions of
included questionnaires vary from 6.4% for England to
47.2% for Germany (see Table 2). The proportion of in-
cluded questionnaires is smallest in England because
about 40% of all respondents in this sample were of Ban-
gladeshi ethnicity who, due to lower levels of stated pro-
ficiency in the English language, did not meet the
inclusion criteria. In total 829 (13.3%) of the included
questionnaires had no missing data for the investigated
variables (see Table 2). There are study region differ-
ences with regard to all investigated variables except for
gender, and for kidney problems (see Table 3). In the
sample of all included patients, the numbers of visits per
year range from zero to 40 with a mean of 3.9 and a
standard deviation of 3.1 (see Table 3).
The results of the Poisson regressions for predicting
yearly provider visits are largely the same when patients
with up to two missing values and when only patients
with complete data are included (See Table 4). In both
cases, the model predicts visit frequency essentially bet-
ter than the mean (in both cases: p < 0.001). When pa-
tients with missing data are considered, the CW-Index is
0.19. When only patients with complete data are consid-
ered, it is 0.18. The control variables contribute largely
to the model prediction (See Table 4). There are statisti-
cally significant negative relationships of travel distance
and in-practice waiting time with visit frequency. For
travel distance, this relationship is large; for in-practice
waiting time it is small. The relationship between travel
time and visit frequency is not statistically significant.
Quality of communication has a very strong statistically
Table 2 General information about the sample
English region Finnish region German region Greek region Dutch region Spanish region Total sample
Statistics determining the study samplea
Questionnaires distributed 3343 436 462 600 779 625 6245
Questionnaires returned 475 (14.2%) 183 (42.0%) 286 (61.9%) 179 (29.8%) 400 (51.3%) 115 (18.4%) 1638 (26.2%)
Sufficient language competenceb 313 (9.4%) 183 (42.0%) 282 (61.0%) 179 (29.8%) 387 (49.7%) 115 (18.4%) 1459 (23.4%)
Sufficient datac 286 (8.6%) 135 (31.0%) 221 (47.8%) 153 (25.5%) 304 (39.0%) 71 (11.4%) 1170 (18.7%)
Participants included 213 (6.4%) 135 (31.0%) 218 (47.2%) 153 (25.5%) 296 (38.0%) 71 (11.4%) 1086 (17.4%)
Complete datad 160 (4.8%) 103 (23.6%) 172 (37.2%) 110 (18.3%) 227 (29.1%) 57 (9.1%) 829 (13.3%)
a Percentages refer to questionnaires distributed
b The English sample contained a large proportion of persons with Bangladeshi ethnicity who had lower levels of stated proficiency in the English language
c Participants with complete data for the criterion variable and the four focal predictor variables and with at most two missing values for the control variables
d Participants with complete data for all investigated variables
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Table 3 Distributions of the investigated variables
English region Finnish region German region Greek region Dutch region Spanish region Total sample Region differencesa
Control variablesb
Gender
Valid data 209 132 217 153 290 70 1071
Male 64.6% 65.2% 53.9% 58.2% 59.3% 55.7% 59.6% n.s.c
Age in years
Valid data 211 133 218 153 294 71 1080
Mean (SD) 63.0 (11.9) 63.5 (9.6) 65.7 (11.2) 66.0 (10.6) 65.0 (10.0) 69.3 (11.4) 65.0 (10.9) p < 0.001d
Education
Valid data 191 129 211 150 287 68 1036
High 39.8% 59.7% 66.4% 27.3% 76.3% 26.5% 55.1% p < 0.001c
Stage of diabetes
Valid data 204 124 207 125 276 63 999
Diet only 13.7% 3.2% 7.7% 1.6% 19.9% 4.8% 10.8% p < 0.001c
Oral, no insulin 65.7% 69.4% 58.9% 68.8% 65.9% 63.5% 65.1%
Insulin 20.6% 27.4% 33.3% 29.6% 14.1% 31.7% 24.1%
Heart problems
Valid data 207 126 193 144 284 70 1024
Yes 25.1% 19.0% 21.8% 30.6% 14.8% 18.6% 21.2% p < 0.01c
Previous stroke
Valid data 212 135 217 151 289 70 1074
Yes 7.5% 2.2% 10.6% 6.0% 4.5% 5.7% 6.3% p < 0.05c
Problems with lower extremities
Valid data 206 134 215 148 283 71 1057
Yes 17.0% 12.7% 26.0% 12.2% 5.3% 15.5% 14.4% p < 0.001c
Problems with sight
Valid data 210 133 216 151 292 70 1072
Yes 24.3% 10.5% 17.6% 15.9% 8.6% 28.6% 16.0% p < 0.001c
Problems with kidney
Valid data 207 133 212 145 286 71 1054
Yes 0.5% 0.0% 0.9% 0.7% 0.0% 0.0% 0.4% n.s.c
Focal predictorse
Travel distance to provider in kilometres
Mean (SD) 1.6 (2.9) 9.2 (10.7) 5.7 (6.1) 15.8 (20.6) 1.9 (1.8) 1.5 (1.3) 5.4 (10.4) p < 0.001d
Travel time to provider in minutes
Mean (SD) 14.6 (9.9) 16.7 (11.5) 13.1 (9.2) 28.8 (25.9) 7.7 (5.1) 14.4 (9.8) 14.7 (14.2) p < 0.001d
In-practice waiting time in minutes
Mean (SD) 18.5 (13.9) 13.7 (10.3) 43.6 (32.5) 52.8 (41.1) 12.9 (19.6) 38.2 (30.0) 27.5 (30.1) p < 0.001d
Quality of communicationf
Mean (SD) 3.9 (1.2) 4.2 (1.0) 4.2 (1.1) 3.9 (1.3) 4.4 (1.0) 3.5 (1.5) 4.1 (1.2) p < 0.001d
Criterion variablee
Numbers of physician visits per year
Mean (SD) 3.3 (3.0) 2.5 (1.4) 4.6 (4.0) 4.9 (4.3) 3.7 (1.3) 4.6 (5.9) 3.9 (3.3) p < 0.001d
a n.s. not significant
b Valid data vary due to missing values
c Pearson’s chi-square test
Kruskal-Wallis teste
e Valid data are identical with the numbers of participants included (see Table 1)
f Coded from 1 for worst quality to 5 for best quality
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significant positive relationship with visit frequency (See
Table 4).
The correlations between the four focal predictors are
largely the same for patients with up to two missing
values and for patients with complete data. Quality of
communication does not correlate with travel distance
and travel time. In the remaining cases, the correlations
deviate from zero on the 0.001 level. For travel distance
and travel time, the correlations are 0.696 for patients
with up to two missing values and 0.698 for patients
with complete data. For travel distance and in-practice
waiting time, these values are 0.215 and 0.254. For travel
time and in-practice waiting time, they are 0.273 and
0.286. For in-practice waiting time and quality of com-
munication, they are − 0.132 and − 0.150. When travel
time or in-practice waiting time are removed from the
model, the pattern for the coefficients of the remaining
three focal predictors stays unaltered both for patients
with up to two missing values and for patients with
complete data. When travel distance is removed, the co-
efficient pattern for the remaining three variables stays
largely the same for patients with complete data, but for
patients with up to two missing values a slightly negative
statistically significant effect of travel time comes into
existence. When quality of communication is removed,
the results are largely the same for patients with up to
two missing data and for patients with complete data.
In both cases, the results for travel distance and in-
practice waiting time stay largely unaltered, but a
slightly positive statistically significant effect of travel
time arises, i.e. the visit frequency increases with in-
creasing travel time.
When terms for the interaction between study regions
and focal predictors are added, the model predicts visit
frequency essentially better than the mean (for patients
with up to two missing values and for patients with
Table 4 Prediction of yearly patient visits to the primary diabetes care provider
Participants with up to two missing values (n = 1086) Patients with complete data (n = 829)
Parametera %-changeb %-contc Parametera %-changeb %-contc
Constant 0.540*** 0.577***
Control variables
Finnish regiond − 0.218** −19.59 7.77 − 0.248** −21.94 8.64
German regiond 0.361*** 43.48 0.330*** 39.08
Greek regiond 0.541*** 71.77 0.545*** 72.46
Dutch regiond 0.163** 17.70 0.163** 17.74
Spanishd 0.411*** 50.83 0.515*** 67.30
Male gender − 0.001 − 0.10 0.03 − 0.001 − 0.12 0.03
Age in years 0.043 4.39 0.08 0.036 3.69 0.06
High education − 0.059 −5.73 0.12 −0.051 −4.99 0.10
Oral medicaments, no insuline 0.107 11.29 0.80 0.122 12.96 0.53
Insuline 0.241*** 27.25 0.208** 23.16
Heart problems 0.044 4.50 0.06 0.058 5.95 0.10
Previous stroke 0.166** 18.06 0.34 0.109 11.47 0.12
Extremities problems 0.332*** 39.38 2.37 0.330*** 39.05 2.36
Sight problems −0.017 −1.69 0.01 − 0.023 −2.26 0.01
Kidney problems −0.938** −60.86 0.53 −0.856** −57.53 0.58
Focal predictors
Travel distance (km) −0.011*** −1.09 1.06 −0.010*** −0.99 0.97
Travel time (minutes) 0.002 0.20 0.09 0.003 0.30 0.20
In-practice waiting time (minutes) −0.001* − 0.10 0.21 − 0.002* − 0.16 0.30
Quality of communicationf 0.127*** 13.54 3.71 0.121*** 12.85 3.26
a Asterisks behind the values symbolize statistical significances for deviation from zero with * = p < 0.05, ** = p < 0.01, and *** = p < 0.001
b Percentage of increase or, respectively, decrease of yearly visits when the respective predictor variable increases for one unit
c Contribution of the respective predictor variable to the prediction of the complete model (one hundred times the difference between the CW-Indices for the
complete model and the models without the respective predictor variable)
d The reference category is England
e The reference category is treatment only by diet
f Coded from 1 for worst quality to 5 for best quality
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complete data: p < 0.001). The CW-indices increase es-
sentially, from 0.18 to 0.24 for patients with up to two
missing values and from 0.19 to 0.25 for patients with
complete data. The patterns of coefficients and the cor-
responding statistical significances are largely the same
for both groups of patients. The interaction of study re-
gions with travel time is not statistically significant; the
interactions with the remaining three focal predictors,
however, are highly significant (see Table 5). For travel
distance and in-practice waiting time there are even sta-
tistically significant effects in opposite directions. To be
specific, in both patient groups, visit frequency increases
significantly with travel distance in the English region,
whereas the opposite is true in the Greek region. In a
similar way, visit frequency increases significantly with
in-practice waiting time in the Spanish region, whereas
Table 5 Prediction of yearly patient visits to the primary diabetes care provider; country specific coefficients for focal predictorsa
English region Finnish region German region Greek region Dutch region Spanish region Country
differencesb
Participants with up to two missing values (n = 1086)
Travel distance in kilometres 0.027** 0.005 −0.009 −0.015*** − 0.005 −0.110* 1.02***
Travel time in minutes 0.004 0.000 −0.002 0.005* −0.003 0.012* 0.24
In-practice waiting time in minutes −0.002 −0.014* 0.001 −0.006*** − 0.001 0.006*** 2.16***
Quality of communicationc 0.163*** 0.133* 0.142*** 0.030 0.068* 0.315*** 1.56***
Patients with complete data (n = 829)
Travel distance in kilometres 0.025* 0.006 −0.003 −0.014*** 0.002 −0.112 1.15**
Travel time in minutes 0.004 0.001 0.001 0.006** −0.004 0.015* 0.32
In-practice waiting time in minutes −0.009* −0.020* 0.002 −0.009*** − 0.007 0.006*** 4.04***
Quality of communicationc 0.127** 0.190* 0.159*** 0.004 0.068 0.228*** 1.12**
a Parameters of Poisson regression when the respective country is taken as reference for the interactions. Statistical significances for deviation from zero are
symbolised with * = p < 0.05, ** = p < 0.01, and *** = p < 0.001
b Contribution of the respective interactions to the prediction of the model with interactions for all four focal predictors, i.e. one hundred times the difference
between the CW-Indices for the model with interactions for all focal predictors and the models without interactions for the respective focal predictor. The
statistical test was performed using a likelihood ratio test between both models. Statistical significances are symbolised with * = p < 0.05, ** = p < 0.01,
and *** = p < 0.001
c Coded from 1 for worst quality to 5 for best quality
Table 6 Prediction of yearly patient visits to the primary diabetes care provider; Reibling category specific coefficients for focal
predictorsa
Strong gatekeeping, low supply
(England, the Netherlands, Spain)
Mixed regulation
(Finland)
Weakly regulated, high supply
(Germany, Greece)
Differences between
categoriesb
Participants with up to two missing values (n = 1086)
Sample sizes 580 135 371
Travel distance in kilometres 0.011 0.005 −0.014*** 0.54**
Travel time in minutes 0.002 0.000 0.003 0.01
In-practice waiting time in minutes 0.001 −0.015* −0.002** 0.55**
Quality of communicationc 0.161*** 0.132* 0.085*** 0.29*
Patients with complete data (n = 829)
Sample sizes 444 103 282
Travel distance in kilometres 0.008 0.006 −0.014*** 0.59**
Travel time in minutes 0.002 0.000 0.004* 0.03
In-practice waiting time in minutes 0.001 −0.020* −0.002** 0.67**
Quality of communicationc 0.137*** 0.187* 0.092*** 0.15
a Parameters of Poisson regression when the respective category is taken as reference for the interactions. Statistical significances for deviation from zero are
symbolised with * = p < 0.05, ** = p < 0.01, and *** = p < 0.001
b Contribution of the respective interactions to the prediction of the model with interactions for all four focal predictors, i.e. one hundred times the difference
between the CW-Indices for the model with interactions for all focal predictors and the models without interactions for the respective focal predictor. The
statistical test was performed using a likelihood ratio test between both models. Statistical significances are symbolised with * = p < 0.05, ** = p < 0.01,
and *** = p < 0.001
c Coded from 1 for worst quality to 5 for best quality
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the opposite is true for the Finnish and Greek regions.
In contrast, visit frequency increases with quality of
communication in all regions and, in most cases, this in-
crease is statistically significant. The study regions only
differ with regard to the extent of the increase. It is
smallest for the Greek and largest for the Spanish region
(see Table 5).
When the interaction terms for study regions are re-
placed by interaction terms with the Reibling categories,
the model also predicts visit frequency better than the
mean (for patients with up to two missing values and for
patients with complete data: p < 0.001). However, the
CW-indices are only slightly higher than the correspond-
ing indices of the models without any interaction terms.
These indices are 0.20 for both patient groups. Apart
from this, the general pattern of results is similar to
the pattern of results for interactions with study regions.
There are statistically significant interaction effects with
travel distance and in-practice waiting time in both pa-
tient groups and a statistically significant interaction ef-
fect for quality of communication for patients with up to
two missing values (see Table 6). There are coefficients
in opposite direction for travel distance and in-practice
waiting time. However, the only coefficients that are sta-
tistically significant are negative (see Table 6). This ap-
plies to travel distance and to in-practice waiting time in
both patient groups (see Table 6), i.e. in these cases visit
frequency decreases with increasing travel distance and
in-practice waiting time. For quality of communication,
all coefficients are positive and statistically significant, i.e.
visit frequency increases with quality of communication
(see Table 6).
Discussion
Discussion of the study methodology
Generalisability
The study regions and the institutions within the study
regions were selected because of their willingness to co-
operate in the research project. Hence, the study regions
cannot be taken as prototypical examples of all regions
in the corresponding country. For each institution, all
eligible patients were approached to participate in the
survey, but only a subset of them responded and some
of those responders had to be excluded for reasons of in-
sufficient mastery of the questionnaire language or insuf-
ficient provision of valid data. Hence, the samples finally
included are not even representative of the populations
of eligible patients within the study regions. The persons
represented by these samples are cooperative and thor-
ough, and native or well-integrated citizens.
Regarding interpretation of the results, the selection
bias in the participants implies that the results should
only be referred to the native and the well-integrated cit-
izens in the study region. This is so, because the study
gives no information as to what would hold for non-
native or not well-integrated citizens. As far as the selec-
tion bias is caused by willingness to cooperate and thor-
oughness, the situation is slightly different. Participants
who have answered all questions can be considered to
be more cooperative and more thorough than those who
left out one or two questions. Hence, the sensitivity ana-
lyses indicate how willingness to cooperate and thor-
oughness might affect the results. When the results for
patients with up to two missing values are largely the
same as those for patients with complete data then this
indicates that the effect found in the analysis might hold
in the region specific population of all native or well-
integrated patients with type 2 diabetes.
The manner in which the study regions have been se-
lected implies that the results found in the region cannot
readily be generalised to the corresponding country.
However, country-specific characteristics constitute one
possible explanation of similarities and differences
between the results from different study regions. An al-
ternative explanation is that these similarities and differ-
ences are caused by other study region characteristics
that are not representative of the corresponding coun-
tries. Comparison of the results from across the different
study regions gives some information regarding the gen-
eralisability of results. Where results differ between the
regions, this shows that these results depend on special
features of the study regions and/or the corresponding
patients. However, when the results are stable across the
regions this indicates that similar results might be found
in different regions. In this regard, performing a study
with data from six different European provider networks
with different participant samples constitutes an import-
ant strength of the study.
Study design
The study presented here is a cross-sectional study and
so it is unclear as to whether the relationships found are
actually causal and, if so, which variable is the cause and
which the effect. To test this, a randomised controlled
trial (RCT) would be necessary and such a study design
is usually not feasible in this context. Therefore, health
care design is dependent on empirical studies using
weaker designs than RCTs (such as cross-sectional stud-
ies). To assess whether the relationships found in such
studies are causal and what the direction of causality
might be, further knowledge about the target of investiga-
tion must also be considered. The best that cross-sectional
designs can produce are empirically well-substantiated
hypotheses regarding causal relationships and the results
presented here are to be understood precisely in this way. It
is up to the health care designers to decide whether they
consider the empirical substantiation as sufficient to base
interventions on them. When these interventions are
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evaluated using RCTs, these evaluation studies constitute
tests of the causality assumptions on which the interven-
tions are based.
Multiple testing
As the effects of several different variables were tested at
the same time, concerns regarding an increased prob-
ability of false positive results due to multiple testing
might arise. However, as the statistical tests were per-
formed as parts of multivariate regression models and as
these models were highly statistically significant the dif-
ferent positive results of the significance tests cannot
simply be explained by chance.
Interpretation of the study results
For the data combined across the six study regions a
clear picture seems to emerge. The pattern of results is
largely the same for patients with up to two missing data
and for patients with complete data. Hence, the results
could be generalised to all native or well-integrated pa-
tients in the study regions. The results indicate a moder-
ate negative effect of travel distance on visits to the
diabetes care provider, no effect due to travel time, a
very slight effect of in-practice waiting time and a very
strong effect due to quality of communication (see Table
4). The analyses where focal predictors were alternatively
removed from the model corroborate the interpretation
that it is travel distance and not travel time that nega-
tively affects visit frequency for the aggregated data of
the six study regions. This corresponds to previous re-
search findings as there were more non-significant re-
sults in studies addressing the effect of travel time [6,
15–17] than in studies addressing the effect of travel dis-
tance [6]. However, once again, quality of communica-
tion has the by far largest effect. An increase of 1 on the
five-categorical scale is associated with a 13.54% increase
of visit frequency. Consequently, an increase from the
lowest to the highest category would lead to a 54.16% in-
crease of visit frequency.
When region-specific coefficients for the four focal
predictors are computed, the clear and simple picture
disappears. Except for travel time, there are large differ-
ences between the study regions. For travel distance and
for in-practice waiting time there are even statistically
significant effects in opposite directions. This implies
that there are statistically significant effects that are in-
consistent with previous results and with intuition for
each of the two variables. For travel distance, this holds
for the English region, where this variable has a positive
effect on visit frequency and, for in-practice waiting
time, this holds for the Spanish region, where this vari-
able has a positive effect (see Table 5). The most prob-
able reason for the effect in the English region is that, in
this region, travel distance is correlated with a further
variable that has a positive impact on visit frequency and
that is not contained in the regression model. For the
Spanish region there seems to be something analogue
for in-practice waiting time. The point is that the results
suggest that travel distance and in-practice waiting time
affect visit frequencies differently in different contexts.
Although there is also an interaction effect for quality of
communication, there is an essential commonality be-
tween all six study regions: visit frequencies always in-
crease with quality of communication. In nine of 12
cases, this relationship is even statistically significant
(see Table 5). Hence, there is a high probability that ef-
fects of this kind will also be found in regions that have
not been investigated in this study.
Future development of health care provision might
benefit from understanding reasons why most of the
focal predictors have different relationships to visit fre-
quencies in the different regions. One reason might be
that the impact of the focal predictors is moderated by
the country-specific regulations regarding access to
health care providers. This hypothesis was tested by
grouping the regions according to their country-specific
regulations as described by the classification system of
Reibling and by repeating the computations with this
grouping. With this computation, the interaction effects
strongly decrease, if they remain at all. This suggests that
country-specific regulations regarding access to health
care are not an important reason for different effects of
the focal predictors in the different study regions. There
must be different characteristics of the study region and/
or the study samples that are responsible for the inter-
action effects and identifying these would be a worth-
while subject for further research.
As the increase of visit frequency with quality of com-
munication is the only stable effect, the question rises as
to whether this relationship is causal with quality of
communication as cause and visit frequency as the ef-
fect. As people generally tend to seek out other people
with whom they have good communication, so it might
be reasonable to interpret the relationship found here in
this way. At least, this might be enough to justify the
recommendation to increase quality of communication if
there is an aim to increase the frequency of visits to the
diabetes care provider.
Conclusions
Travel time, when controlled for travel distance, appears
to have no impact on the frequency of visits to the dia-
betes care provider. For travel distance and in-practice
waiting time, the effects are slight and inconsistent across
study regions. In contrast, quality of communication has a
strong positive effect on visit frequency. The strength of
this relationship varies across study regions, but such a re-
lationship was apparent in all of them, at least at a
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descriptive level. Therefore, if one seeks to increase the
frequency of visits to the diabetes care provider increasing
the quality of the provider’s communication with the pa-
tient would be highly recommended.
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